<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0"
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main" xml:id="_FgERPJG">Therapeutic Benefit of Internet-Based Lifestyle Counselling for Hypertension</title>
				<funder ref="#_rVUjyNn">
					<orgName type="full">Heart and Stroke Foundation Health</orgName>
				</funder>
				<funder>
					<orgName type="full">Canadian Stroke Network</orgName>
					<orgName type="abbreviated">CSN</orgName>
					<idno type="DOI" subtype="crossref">https://doi.org/10.13039/100015098</idno>
				</funder>
				<funder ref="#_a9YHxZa">
					<orgName type="full">unknown</orgName>
				</funder>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><roleName>PhD</roleName><forename type="first">Robert</forename><forename type="middle">P</forename><surname>Nolan</surname></persName>
							<email>rnolan@uhnres.utoronto.ca</email>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>a</label> Behavioural Cardiology Research Unit , University Health Network , Toronto , Ontario , Canada</note>
								<orgName type="department">Behavioural Cardiology Research Unit</orgName>
								<orgName type="institution">University Health Network</orgName>
								<address>
									<settlement>Toronto</settlement>
									<region>Ontario</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>b</label> Faculty of Medicine , University of Toronto , Toronto , Ontario , Canada</note>
								<orgName type="department">Faculty of Medicine</orgName>
								<orgName type="institution">University of Toronto</orgName>
								<address>
									<settlement>Toronto</settlement>
									<region>Ontario</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MSc</roleName><forename type="first">Sam</forename><surname>Liu</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>a</label> Behavioural Cardiology Research Unit , University Health Network , Toronto , Ontario , Canada</note>
								<orgName type="department">Behavioural Cardiology Research Unit</orgName>
								<orgName type="institution">University Health Network</orgName>
								<address>
									<settlement>Toronto</settlement>
									<region>Ontario</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>b</label> Faculty of Medicine , University of Toronto , Toronto , Ontario , Canada</note>
								<orgName type="department">Faculty of Medicine</orgName>
								<orgName type="institution">University of Toronto</orgName>
								<address>
									<settlement>Toronto</settlement>
									<region>Ontario</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">J</forename><forename type="middle">Kevin</forename><surname>Shoemaker</surname></persName>
							<affiliation key="aff2">
								<note type="raw_affiliation"><label>c</label> School of Kinesiology Faculty of Health Sciences , and Department of Physiology and Pharmacology , The University of Western Ontario , London , Ontario , Canada</note>
								<orgName type="department" key="dep1">School of Kinesiology Faculty of Health Sciences</orgName>
								<orgName type="department" key="dep2">Department of Physiology and Pharmacology</orgName>
								<orgName type="institution">The University of Western Ontario</orgName>
								<address>
									<settlement>London</settlement>
									<region>Ontario</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Vladimir</forename><surname>Hachinski</surname></persName>
							<affiliation key="aff3">
								<note type="raw_affiliation"><label>d</label> Department of Neurology , University of Western Ontario , London , Ontario , Canada</note>
								<orgName type="department">Department of Neurology</orgName>
								<orgName type="institution">University of Western Ontario</orgName>
								<address>
									<settlement>London</settlement>
									<region>Ontario</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Hazel</forename><surname>Lynn</surname></persName>
							<affiliation key="aff4">
								<note type="raw_affiliation"><label>e</label> Grey-Bruce Public Health Unit , Owen Sound , Ontario , Canada</note>
								<orgName type="department">Grey-Bruce Public Health Unit</orgName>
								<orgName type="institution">Owen Sound</orgName>
								<address>
									<region>Ontario</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">David</forename><forename type="middle">J</forename><surname>Mikulis</surname></persName>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>b</label> Faculty of Medicine , University of Toronto , Toronto , Ontario , Canada</note>
								<orgName type="department">Faculty of Medicine</orgName>
								<orgName type="institution">University of Toronto</orgName>
								<address>
									<settlement>Toronto</settlement>
									<region>Ontario</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Richard</forename><forename type="middle">A</forename><surname>Wennberg</surname></persName>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>b</label> Faculty of Medicine , University of Toronto , Toronto , Ontario , Canada</note>
								<orgName type="department">Faculty of Medicine</orgName>
								<orgName type="institution">University of Toronto</orgName>
								<address>
									<settlement>Toronto</settlement>
									<region>Ontario</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MBA</roleName><forename type="first">Margaret</forename><forename type="middle">Moy</forename><surname>Lum-Kwong</surname></persName>
							<affiliation key="aff5">
								<note type="raw_affiliation"><label>f</label> Heart and Stroke Foundation of Ontario , Toronto , Ontario , Canada</note>
								<orgName type="department">Heart and Stroke Foundation of Ontario</orgName>
								<address>
									<settlement>Toronto</settlement>
									<region>Ontario</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Ahmad</forename><surname>Zbib</surname></persName>
							<affiliation key="aff5">
								<note type="raw_affiliation"><label>f</label> Heart and Stroke Foundation of Ontario , Toronto , Ontario , Canada</note>
								<orgName type="department">Heart and Stroke Foundation of Ontario</orgName>
								<address>
									<settlement>Toronto</settlement>
									<region>Ontario</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff6">
								<note type="raw_affiliation">Behavioural Cardiology Re- search Unit , 6N-618 NU ,</note>
								<orgName type="department">Behavioural Cardiology Re- search Unit</orgName>
								<orgName type="institution">NU</orgName>
								<address>
									<postCode>6N-618</postCode>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff7">
								<note type="raw_affiliation">University Health Network , 585 University Ave- nue , Toronto , Ontario M5G 2N2 , Canada.</note>
								<orgName type="institution">University Health Network</orgName>
								<address>
									<addrLine>585 University Ave- nue</addrLine>
									<postCode>M5G 2N2</postCode>
									<settlement>Toronto</settlement>
									<region>Ontario</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main" xml:id="_SfnfSVh">Therapeutic Benefit of Internet-Based Lifestyle Counselling for Hypertension</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">D8B9C31D1599EDA67299C8B78C1E019E</idno>
					<idno type="DOI">10.1016/j.cjca.2012.02.012</idno>
					<note type="submission">Received for publication November 30, 2011. Accepted February 21, 2012.</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-08-31T10:58+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">a91ee48</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=2, consolidateHeader=2, consolidateFunders=1, includeRawAffiliations=true, includeRawCitations=true, includeRawCopyrights=true, generateTeiIds=true, generateTeiCoordinates=[all], sentenceSegmentation=true, flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_eGGeTSk"><p xml:id="_4v4fyAe"><s xml:id="_f7mzEEG">Background: Preventive electronic (e)-counselling has been shown to reduce cardiovascular risk factors.</s><s xml:id="_SjxprXa">However, heterogeneity in outcomes is commonly reported due to differences in e-protocols.</s><s xml:id="_AAHvAh2">We incorporated key features of an established behavioural therapy, motivational interviewing, to help standardize e-counselling in order to reduce blood pressure in patients with hypertension.</s><s xml:id="_pRCPV5M">Methods: Subjects (n ϭ 387, mean age ϭ 56 years, 59% female, 72% taking Ն 1 antihypertensive drug) were diagnosed with stage 1 or 2 hypertension.</s><s xml:id="_b4uBvaj">Subjects were randomized to a 4-month protocol of e-counselling (beta version of the "Blood Pressure Action Plan", Heart and Stroke Foundation of Canada) vs waitlist control (general e-information on heart-healthy living).</s><s xml:id="_hQafWFS">Outcomes were sys-</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<facsimile>
		<surface n="1" ulx="0.0" uly="0.0" lrx="585.0" lry="783.0"/>
		<surface n="2" ulx="0.0" uly="0.0" lrx="585.0" lry="783.0"/>
		<surface n="3" ulx="0.0" uly="0.0" lrx="585.0" lry="783.0"/>
		<surface n="4" ulx="0.0" uly="0.0" lrx="585.0" lry="783.0"/>
		<surface n="5" ulx="0.0" uly="0.0" lrx="585.0" lry="783.0"/>
		<surface n="6" ulx="0.0" uly="0.0" lrx="585.0" lry="783.0"/>
		<surface n="7" ulx="0.0" uly="0.0" lrx="585.0" lry="783.0"/>
	</facsimile>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_FbcjDYj">RÉSUMÉ</head><p xml:id="_stwdey4"><s xml:id="_HXNGdea">Introduction : Il a été démontré que le counselling préventif en ligne réduisait les facteurs de risque cardiovasculaire.</s><s xml:id="_kBmQtE8">Cependant, on rapporte généralement l'hétérogénéité des résultats en raison des différences dans les protocoles en ligne.</s><s xml:id="_fraNmJD">Nous avons inclus les caractéristiques clés d'une thérapie comportementale établie, l'entretien motivationnel, pour contribuer à l'uniformisation du counselling en ligne afin de réduire la pression artérielle chez les patients souffrant d'hypertension.</s><s xml:id="_HSQQFYk">Méthodes : Les sujets (n ϭ 387, âge moyen ϭ 56 ans, 59 % de sexe féminin, 72 % prenant Ն 1 médicament antihypertenseur) avaient un diagnostic d'hypertension au stade 1 ou 2. Les sujets étaient répartis au hasard entre un protocole de 4 mois de counselling en ligne (version bêta du Plan d'action de tension artérielle MC de la Fondation des Recommendations for the treatment of hypertension advocate the combined use of pharmacotherapy and lifestyle counselling in order to achieve blood pressure control and to lower risk for cardiovascular events. <ref type="bibr" target="#b0">1</ref> A major challenge for a communitybased preventive strategy is to extend the reach of therapeutic lifestyle counselling to individuals with hypertension.</s><s xml:id="_MJqdBqS">Systematic reviews suggest telehealth or electronic (e)-based counselling programs may be well-suited to meet this challenge. <ref type="bibr" target="#b1">2,</ref><ref type="bibr" target="#b2">3</ref></s><s xml:id="_ZCW3fRQ">eta-analytic reviews indicate that patient education, exercise training, and diet modification, provided by conventional programs or by e-based or telehealth protocols, significantly decrease cardiovascular risk factors. <ref type="bibr" target="#b3">[4]</ref><ref type="bibr" target="#b4">[5]</ref></s><s xml:id="_hakNDyh">5]<ref type="bibr" target="#b5">[6]</ref> In the context of hypertension, these reviews report that systolic blood pressure is lowered in the range of 3.0-8.7 mm Hg relative to controls.</s><s xml:id="_zVBgugY">However, a commonly reported observation is that there is significant heterogeneity in clinical outcomes due to substantial differences in the content or clinical method of e-based or telehealth interventions.</s><s xml:id="_Fgj7nRT">Currently, these protocols can include several optional components: (1) supplementary patient-provider contact, (2) utilization of devices for home-based monitoring of symptoms such as blood pressure, (3) automated messaging that provides advice, education, and support for behaviour change, (4) self-assessment tools to monitor progress in behaviour change, and (5) patient-controlled menus to navigate counselling materials, in order to promote motivation and efficacy in behaviour change skills.</s><s xml:id="_3ueuytb">A priority advocated by our team is to work toward establishing a core protocol for preventive e-counselling by incorporating key components from established, evidence-based behavioural therapies that have been shown to (1) improve patient motivation for change, and (2) reduce psychological distress, which is a barrier to sustained change.</s></p><p xml:id="_TmKSSUP"><s xml:id="_RXqvgNV">The primary objective of this trial (the Internet-Based Strategic Transdisciplinary Approach to Risk Reduction and Treatment [I-START]) was to evaluate whether a standardized protocol of e-counselling, with key features to augment motivation for behaviour change, independently lowered systolic and diastolic blood pressure as well as pulse pressure in hypertensive individuals, independent of both medications and validated measures of psychological distress.</s><s xml:id="_uJvtbzt">Secondary outcomes included change in self-reported exercise and diet, as well as lipoprotein cholesterol.</s><s xml:id="_H2RCVj4">We recently reported that e-counselling in the present trial independently evoked therapeutic change in exercise and diet. <ref type="bibr" target="#b6">7</ref></s><s xml:id="_qXYZV74">Therefore, this report presents the main results for I-START, which include an evaluation of the independent effect of e-counselling on blood pressure and cholesterol.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_gVCtfb5">Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_JYPkEDf">Study population</head><p xml:id="_mdp5Ypu"><s xml:id="_EmFWXZP">Subjects were 45-74 years of age and diagnosed with stage 1 or 2 hypertension: systolic/diastolic blood pressure, 140-159/ 90-99 mm Hg, or 160-180/100-110 mm Hg, respectively.</s><s xml:id="_fGF7ATS">Exclusion was based on established psychiatric illness (eg, psychosis) or drug or alcohol dependence in the previous year, as well as residence in an institutional setting.</s><s xml:id="_d2eTU5z">Medications were not altered by design.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_prkwkrN">Study design</head><p xml:id="_GjrnSfK"><s xml:id="_QUtDxpG">I-START was a 2 parallel-group, single-blind randomized controlled trial.</s><s xml:id="_uXh6RyQ">Subjects were randomized to e-counselling or to a wait list control group and assessed at baseline and at 4-month follow-up.</s><s xml:id="_X7dEqgr">Randomization was blocked within our 3 recruitment sites in Ontario, Canada (Greater Toronto Area, London, and the Grey Bruce Region) and stratified according to sex and age by means of a computer program.</s><s xml:id="_tDpmHtt">The randomization codes were hidden in sealed, opaque envelopes that were sorted by stratification features at each site.</s><s xml:id="_gzxCguP">Research assistants who conducted the assessments were blind to the research design and randomized status of subjects.</s><s xml:id="_E6VNdym">All patients completed informed consent prior to participating in the study, and approval was obtained from the Research Ethics Board of each institution.</s></p><p xml:id="_nrHgzWt"><s xml:id="_DaQe9ch">Recruitment was conducted by self-referral after subjects logged onto the website of the Heart and Stroke Foundation of Canada.</s><s xml:id="_ZkYQYpN">Subjects were asked to indicate whether they (1) were diagnosed with "high blood pressure" by their doctor, (2) resided in our 3 recruitment areas, and (3) were willing to provide contact information in order to participate in the present research project.</s><s xml:id="_h9cjhjS">A telephone screening interview was administered to eligible subjects.</s><s xml:id="_9meUEnp">Those meeting inclusion criteria were mailed a study information package and a patient profile form.</s><s xml:id="_FTyM6G4">The latter form requested their family physician to confirm their diagnosis of hypertension.</s><s xml:id="_8PDdAQ3">Subjects who met inclusion criteria after physician confirmation were then scheduled for an assessment at a local I-START clinic.</s><s xml:id="_XSffeXE">These clinics were located in family medicine outpatient clinics, a behavioural cardiology research unit in a tertiary care hospital, and a university-based neurovascular laboratory (urban sites), and 1 public health unit (rural site) in Ontario, Canada.</s></p><p xml:id="_VVgyvc5"><s xml:id="_cc2HadC">The e-counselling intervention was designed to proactively deliver 8 e-messages over the 4-month interval according to the following schedule: weekly e-mails in month 1, bi-weekly e-mails in month 2, and monthly e-mails in months 3 and 4.</s><s xml:id="_KGGUGTK">These e-counselling messages were sent from the "Blood Pressure Action Plan" (BPAP) (Heart and Stroke Foundation of Canada, 2011), which was a beta version of the Heart and Stroke Foundation e-platform to promote blood pressure control (<ref type="url" target="http://www.heartandstroke.on.ca/site/c.pvI3IeNWJwE/b.3582093/k.8AB3/Blood_Pressure_Action_Plan.htm">http://www.heartandstroke.on.ca/site/c.pvI3IeNWJwE/  b.3582093/k.8AB3/Blood_Pressure_Action_Plan.htm</ref>).</s><s xml:id="_FejQV9q">This program initially guided subjects to report their stage of motivational "readiness" to adhere to Health Canada guidelines for tolic, diastolic, and pulse pressures, and total lipoprotein cholesterol after treatment.</s><s xml:id="_xsjX3ws">Results: Intention to treat analysis did not find a significant group difference in outcomes due to contamination across the 2 arms of this trial.</s><s xml:id="_wqjFaVA">However, per protocol analysis indicated that subjects receiving Ն 8 e-counselling messages (a priori therapeutic dose) vs 0 e-counselling messages (control) demonstrated greater reduction in systolic blood pressure (mean, Ϫ8.9 mm Hg; 95% confidence interval [CI], Ϫ11.5 to Ϫ6.4 vs Ϫ5.0 mm Hg; 95% CI, Ϫ6.7 to Ϫ3.3, P ϭ 0.03), pulse pressure (Ϫ6.1 mm Hg; 95% CI, Ϫ8.1 to Ϫ4.1 vs Ϫ3.1 mm Hg; 95% CI, Ϫ4.3 to Ϫ1.8, P ϭ 0.02) and total cholesterol (Ϫ0.24 mmol/L; 95% CI, Ϫ0.43 to Ϫ0.06 vs 0.05 mmol/L; 95% CI, Ϫ0.06 to 0.16, P ϭ 0.03), but not diastolic blood pressure.</s><s xml:id="_QBhFPwX">Conclusions: These findings support the merit of evaluating whether e-counselling can improve blood pressure control and reduce cardiovascular risk over the long-term.</s><s xml:id="_Kyv8r4h">maladies du coeur) et un groupe témoin en liste d'attente (information générale en ligne sur le mode de vie favorisant la santé cardiaque).</s><s xml:id="_pQv7azm">Les résultats étaient les pressions systolique, diastolique et différentielle, et le cholestérol total après le traitement.</s><s xml:id="_7E5C47n">Résultats : L'analyse selon l'intention de traiter n'a pas révélé de différence significative entre les résultats des groupes en raison de la contamination dans les 2 bras de cet essai.</s><s xml:id="_96Z6QEZ">Cependant, l'analyse selon le respect du protocole indiquait que les sujets recevant Ն 8 messages de counselling en ligne (la dose thérapeutique a priori) par rapport à ceux ne recevant aucun (0) message de counselling en ligne (groupe témoin) démontrait une plus grande réduction de la pression artérielle systolique (moyenne, Ϫ8,9 mm Hg; intervalle de confiance [IC] de 95 %, Ϫ11,5 à Ϫ6,4 vs Ϫ5,0 mm Hg; IC de 95 %, Ϫ6,7 à Ϫ3,3, P ϭ 0,03), pression différentielle (Ϫ6,1 mm Hg; IC de 95 %, Ϫ8,1 à Ϫ4,1 vs Ϫ3,1 mm Hg; IC de 95 %, Ϫ4,3 à Ϫ1,8, P ϭ 0,02) et cholestérol total (Ϫ0,24 mmol/l; IC de 95 %, Ϫ0,43 à Ϫ0,06 vs 0,05 mmol/l; IC de 95 %, Ϫ0,06 à 0,16, P ϭ 0,03), mais non pas de la pression artérielle diastolique.</s><s xml:id="_RFdbtyw">Conclusions : Ces conclusions reconnaissent le mérite d'évaluer si le counselling en ligne peut améliorer la maîtrise de la pression artérielle et réduire le risque cardiovasculaire à long terme.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_5gvEGWf">Nolan et al. E-Counselling and Hypertension</head><p xml:id="_G6GNwvm"><s xml:id="_F28KV9s">diet (daily intake of fruit, vegetables, and restriction of dietary fat and salt), exercise (planned exercise and daily activity), and smoke-free living.</s><s xml:id="_xy6Ehbd">As previously reported, <ref type="bibr" target="#b6">7</ref> readiness for change was operationally defined for each behaviour according to the conventional algorithm of Prochaska's Transtheoretical Model 8 (Precontemplation, Contemplation, Preparation, Action, and Maintenance).</s><s xml:id="_77tZYEu">In an effort to reinforce motivation and efficacy for self-directed change, 9 subjects were then prompted to actively choose their priority for lifestyle change from the above-noted behaviours associated with diet, exercise, and smoke-free living.</s><s xml:id="_Gv8mRM4">Moreover, the program provided key messages to promote motivation by validating the effort of subjects to work toward goals for change that were tailored to the self-reported stage of readiness for each behaviour that was selected as a change priority.</s><s xml:id="_VrMch3Z">The BPAP also provided numerous menus that were linked to educational material and self-help tips for lifestyle change.</s><s xml:id="_gRVpQ7j">This feature further permitted subjects to self-direct their change plan, which was consistent with cognitive-behavioural guidelines to reinforce motivation and efficacy for initiating and maintaining behaviour change. <ref type="bibr" target="#b9">10</ref></s><s xml:id="_3kGFn8P">In contrast, subjects randomized to the control condition received He@lthline e-newsletters from the Heart and Stroke Foundation that contained general information and advice for heart-healthy living.</s><s xml:id="_4ACpzWC">In addition, they agreed to refrain from logging onto the Heart and Stroke Foundation BPAP over their 4-month interval of participation in this study.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_AJ3Jf3H">Measures</head><p xml:id="_NNpfEjn"><s xml:id="_pxtQeqW">Patients were asked to refrain from smoking, exercise, and caffeine for 4 hours before their appointment.</s><s xml:id="_rMEF2UQ">Baseline measurements were recorded by a trained research assistant for height, weight, body mass index (BMI), waist circumference, and blood pressure (2 measurements, 15 minutes apart).</s><s xml:id="_Efx3Zep">All assessments took place between 8:00 AM and 12:00 noon.</s><s xml:id="_NCKNM6t">Psychological distress was assessed by the Beck Depression Inventory-II <ref type="bibr" target="#b10">11</ref> and the Perceived Stress Scale. <ref type="bibr" target="#b11">12</ref></s><s xml:id="_CfcVc8H">Similarly, exercise and diet behaviours were measured by questionnaire as previously reported. <ref type="bibr" target="#b6">7</ref></s><s xml:id="_jhwvxAg">In brief, the readiness for change algorithm is as follows: Pre-contemplation (not ready to adhere to the target behaviour in the next 6 months), Contemplation (ready to adhere to the target behaviour in the next 6 months), Preparation (ready to adhere to the target behaviour in the next 4 weeks), Action (adhere to the behaviour but for less than 6 months), Maintenance (adhere to the behaviour for 6 months or more).</s><s xml:id="_crA8mg3">Twelve-hour fasting blood samples were collected from patients using a conventional protocol, and total lipoprotein cholesterol analysis was conducted using a common laboratory network.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_qAb2HnS">Statistical analysis</head><p xml:id="_kzXU4KY"><s xml:id="_E637MMZ">Baseline characteristics of the control and e-counselling groups were assessed using analysis of variance.</s><s xml:id="_uVCDaJg">Both intention to treat and per protocol analyses were conducted due to a contamination of the randomized conditions during the early phase of this trial.</s><s xml:id="_7ZRTVCJ">Specifically, it was discovered in the latter phase of this trial that 35 controls (18%) had accessed the e-counselling intervention despite agreeing to wait until the end of the trial to do so.</s><s xml:id="_nNbPgZj">In addition, only 82 e-counselling subjects (42%) received Ն 8 emails over the 4-month interval, which was defined a priori as a "therapeutic" dosage.</s><s xml:id="_p2r2zae">This latter issue was due to a programming problem in which the schedule of proactive e-mails was reset when subjects repeatedly logged into the Heart and Stroke Foundation BPAP and re-entered their registration information.</s><s xml:id="_YxzwrCj">Therefore, a per protocol analysis was conducted with 3 groups according to whether subjects received Ն 8 emails (a priori "therapeutic" dosage of e-counselling), 1-7 emails (subtherapeutic dosage of e-counselling), or 0 e-mails (control).</s><s xml:id="_CXbHpSX">Analysis of covariance (ANCOVA) for change in blood pressure and total cholesterol at the 4-month follow-up adjusted statistically for baseline blood pressure and cholesterol (respectively), sex, age, antihypertensive or lipid-lowering medications, and baseline psychological distress (depression <ref type="bibr" target="#b10">11</ref> and psychological stress <ref type="bibr" target="#b11">12</ref> ).</s><s xml:id="_RcbrFM7">Statistical significance was defined by a 2-tailed test with a P value Ͻ0.05.</s><s xml:id="_vbjHDDe">Analyses were conducted with SPSS (version 17.0; SPSS Inc, Chicago, IL).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_RM6yssP">Results</head><p xml:id="_qCRYs25"><s xml:id="_J6vEut9">A total of 387 subjects with hypertension were enrolled in this trial (Fig. <ref type="figure" target="#fig_0">1</ref>).</s><s xml:id="_uP8cJUm">The sample was sex-balanced, with 59% females.</s><s xml:id="_RZ8CaAk">The mean age was 56 years (95% confidence interval [CI], 45-70) and 41% of subjects were obese according to BMI criteria.</s><s xml:id="_QJwMUxj">Mean systolic/diastolic blood pressure was 140/80 mm Hg (95% CI, 113-172 and 63-99, respectively).</s><s xml:id="_mhdR8A2">Systolic blood pressure was controlled (Ͻ140 mm Hg) among 54% of the sample, while diastolic blood pressure was controlled (Ͻ90 mm Hg) among 83% of subjects.</s><s xml:id="_HYKduGA">Finally, 72% of subjects were prescribed at least 1 antihypertensive drug.</s><s xml:id="_HSAaqnP">Mean total cholesterol was 5.3 mmol/L (95% CI, 3.7-7.0)</s><s xml:id="_5Q4BpW4">while 21% were prescribed a lipid-lowering drug.</s></p><p xml:id="_zE8Mvfk"><s xml:id="_Cf6H3AK">There were no group differences in withdrawals: control, n ϭ 35, 18.1%; e-counselling, n ϭ 45, 23.2%; P ϭ 0.18.</s><s xml:id="_mWPq83r">The intention to treat analysis did not find a significant difference between our randomized groups with regard to change in the primary outcomes: systolic blood pressure (P ϭ 0.75), diastolic blood pressure (P ϭ 0.41), and pulse pressure (P ϭ 0.30).</s><s xml:id="_CWVetra">Total cholesterol was significantly reduced among the e-counselling group vs controls (Ϫ0.13 mmol/L; 95% CI, Ϫ0.26 to Ϫ0.01 vs 0.05 mmol/L; 95% CI, Ϫ0.07 to 0.17; P ϭ 0.04); however, this outcome was not included in the priori hypotheses.</s></p><p xml:id="_xKEeVeD"><s xml:id="_bB4ZFws">As noted in Table <ref type="table" target="#tab_0">1</ref>, the e-counselling groups (0 e-mails, 1-7 e-mails, and Ն8 e-mails) did not differ significantly with regard to age, income, BMI, waist circumference, and cardiovascular risk factors.</s><s xml:id="_CM5HWnq">However, there was a higher prevalence of females in the groups receiving 1-7 e-mails and Ն 8 e-mails.</s><s xml:id="_nVSwfTD">Systolic blood pressure did not differ significantly between controls (0 e-mails) and the groups receiving e-counselling messages.</s><s xml:id="_SFFNGPA">However, systolic blood pressure was significantly lower in the e-counselling group who received 1-7 e-mails, vs Ն8 e-mails.</s></p><p xml:id="_SGAkrcQ"><s xml:id="_ukvK7Gj">In contrast, diastolic blood pressure differed significantly between the 3 e-counselling groups, but post hoc comparisons between controls (0 e-mails) and each of the groups who received e-counselling messages were not statistically significant according to Bonferroni criteria.</s><s xml:id="_8p9MtkD">Table <ref type="table" target="#tab_1">2</ref> shows that antihypertensive and lipid-lowering medications did not differ significantly between the e-counselling groups.</s></p><p xml:id="_k5NkVhA"><s xml:id="_3fk3v7G">The per-protocol analysis demonstrated a significant and incremental association between e-counselling support and therapeutic changes in systolic blood pressure (P ϭ 0.02), pulse pressure (P ϭ 0.02), and total cholesterol (P ϭ 0.002).</s><s xml:id="_MsqUKFu">As shown in Table <ref type="table" target="#tab_2">3</ref>, subjects who received Ն 8 e-counselling messages compared with those who received 0 messages demonstrated greater reduction in blood pressure and total cholesterol.</s><s xml:id="_HPVsuFq">An examination of covariates in the above-noted analyses indicated that baseline symptoms of depression or psychological stress were not independently associated with changes in blood pressure or cholesterol at 4-month follow-up.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_hgQMr24">Discussion</head><p xml:id="_5WxDuSg"><s xml:id="_UtZYTe2">We evaluated the efficacy of a standardized protocol of e-counselling that was designed to contribute to blood pressure reduction among persons diagnosed with hypertension by means of increasing adherence to self-management behaviours for exercise and diet.</s><s xml:id="_7hY4D7M">This trial was distinct insofar as it incorporated key features of motivational interviewing <ref type="bibr" target="#b8">9</ref> into our e-counselling protocol.</s><s xml:id="_cvveqqV">For example, subjects randomized to e-counselling received validating feedback to work toward goals that were matched to each subject's self-assessed stage of readiness for change, in relation to recommended guidelines for exercise (daily activity and formal exercise), diet (fruits, vegetables, fat, and salt) and smoke-free living. <ref type="bibr" target="#b12">13,</ref><ref type="bibr" target="#b13">14</ref></s><s xml:id="_MpbRPs4">Our major finding was that e-counselling was independently associated with decreased systolic blood pressure, pulse pressure, and total cholesterol after adjusting for potential confounding factors such as medication.</s><s xml:id="_Kgmq84Q">Similarly, we have previously reported that adherence to exercise and diet also improved significantly with e-counselling. <ref type="bibr" target="#b6">7</ref></s><s xml:id="_U7KHNNg">his study contributes to the growing body of evidence which indicates that e-counselling may contribute significantly to community-based programs aimed at reducing cardiovascular risk factors among persons with hypertension.</s><s xml:id="_NbnxNkw">Our abovenoted findings are consistent with previous trials of lifestyle counselling, <ref type="bibr" target="#b14">15,</ref><ref type="bibr" target="#b15">16</ref> particularly those that have utilized a telehealth or e-based strategy to modify lifestyle. <ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b17">[18]</ref></s><s xml:id="_EXayzta">8]<ref type="bibr" target="#b18">[19]</ref> Our team previously demonstrated that it is feasible to use an evidencebased model of motivational interviewing within a telehealth protocol for persons at high risk for a primary or secondary cardiovascular event. <ref type="bibr" target="#b19">20</ref></s><s xml:id="_EkzyxvR">We found that this telehealth intervention significantly reduced systolic and diastolic blood pressure, while improving adherence to exercise and diet.</s></p><p xml:id="_vBZxQVX"><s xml:id="_FFhNEST">Neubeck et al. <ref type="bibr" target="#b4">5</ref> recently reported that it was not possible to provide a summary index following meta-analysis of telehealth or internet programs for exercise or diet behaviour due to the heterogeneity in reporting procedures and assessment methods.</s><s xml:id="_wfTjJA5">Nevertheless, among 5 out of the 7 randomized controlled trials, significant improvement in physical activity as measured by functional capacity during exercise treadmill testing or psychometric assessment of self-reported activity was observed, <ref type="bibr" target="#b18">19,</ref><ref type="bibr" target="#b20">[21]</ref><ref type="bibr" target="#b21">[22]</ref><ref type="bibr" target="#b22">[23]</ref><ref type="bibr" target="#b23">[24]</ref> although only 1 out of 4 trials showed improvements in dietary behaviour measured by a validated food frequency questionnaire. <ref type="bibr" target="#b23">24</ref></s><s xml:id="_ybfPPF4">The above-noted findings by our team and others underscores the need to develop a standardized e-counselling protocol that is grounded in an evidence-based model of behavioural counselling.</s><s xml:id="_wNzVHRh">This trial as well as our previous trial <ref type="bibr" target="#b19">20</ref> demonstrated that an e-counselling behavioural program combined with key features of motivational interviewing can significantly augment blood pressure reduction independent of the benefit of antihypertensive medications.</s></p><p xml:id="_5ykZgQ7"><s xml:id="_D5mhSAf">Preventive e-counselling may fill critical gaps in communitybased strategies to promote blood pressure reduction.</s><s xml:id="_3V8CwTk">A recent survey of Canadians with hypertension has shown a monotonic relationship between the number of health care providers who provide advice for therapeutic lifestyle change and increasing levels of adherence to these recommended lifestyle behaviours. <ref type="bibr" target="#b24">25</ref></s><s xml:id="_P9KyFYb">However, 20%-43% of this cohort reported that they did not receive health behaviour advice to change diet, exercise, or smoking as a means of blood pressure control. <ref type="bibr" target="#b24">25</ref></s><s xml:id="_NuVs9kW">In addition, long-term adherence to recommended standards for exercise, diet, and smoke-free living is only low-to-moderate following conventional behaviour change programs. <ref type="bibr" target="#b25">[26]</ref><ref type="bibr" target="#b26">[27]</ref></s><s xml:id="_nBWXbRH">7]<ref type="bibr" target="#b27">[28]</ref> Nonadherence to antihypertensive medication is also considerable, ranging from 15%-50%, <ref type="bibr" target="#b28">29,</ref><ref type="bibr" target="#b29">30</ref> while persistence with antihypertensive medications diminishes over time for approximately 22%-50% of patients. <ref type="bibr" target="#b28">29,</ref><ref type="bibr" target="#b30">31</ref></s><s xml:id="_a46tNy7">Preliminary evidence suggests that e-counselling may promote long-term improvement (over 24 months) in body weight and aerobic fitness. <ref type="bibr" target="#b14">15</ref></s><s xml:id="_keuduFD">These data combined with the present findings suggest that preventive e-counselling Data are presented as mean (95% confidence interval).</s><s xml:id="_8cCGkVf">Change scores defined as assessment after 4-month intervention-baseline assessment.</s><s xml:id="_TAVr9Gz">Analysis of covariance for blood pressure (BP) and cholesterol adjusted for baseline BP or cholesterol, sex, age, antihypertensive or lipid-lowering drugs, and psychological distress (symptoms of depression and stress).</s><s xml:id="_E2xke4W">E-counselling groups: e-mails sent by the Heart and Stroke Foundation Blood Pressure Action Plan; 0 ϭ no e-mails, 1 ϭ 1-7 e-mails, 2 ϭ 8 or more e-mails.</s><s xml:id="_4ztvxpg">Significant group differences relative to the control group (0 e-mails) are indicated by superscript for Bonferroni-corrected P value.</s></p><p xml:id="_cqMZXcw"><s xml:id="_9gzYHzW">* ⌬Systolic BP, P ϭ 0.03.</s><s xml:id="_SUNdkqT">† ⌬Pulse pressure, P ϭ 0.02.</s><s xml:id="_dWKnunQ">‡ ⌬Total cholesterol, P ϭ 0.03.</s></p><p xml:id="_NUXb8GY"><s xml:id="_8hUThux">should be considered a research priority in current communitybased initiatives to reduce blood pressure and risk for cardiovascular events.</s><s xml:id="_nHNGn2x">Within Canada, increased adherence to recommended guidelines for diet, exercise, and smoke-free living is associated with improved longevity and quality of life among individuals with uncontrolled hypertension who are currently prescribed medication, as defined by 0.5-3.4</s><s xml:id="_STAMkAZ">life years gained, and 1.0-2.5 years free of cardiovascular disease. <ref type="bibr" target="#b31">32</ref></s><s xml:id="_MWSCbpZ"> limitation to the present study is that the subjects who were enrolled had demonstrated an initial level of motivation to obtain preventive health information from our recruitment website: Heart and Stroke Foundation BPAP.</s><s xml:id="_aZ4ACKh">Therefore, our findings may generalize only to individuals who are already engaged in health information-seeking behaviour, which corresponds to 58% of home internet users in Canada.</s><s xml:id="_3Xb6Nqd"><ref type="bibr" target="#b32">33</ref> Nevertheless, the potential feasibility of using e-counselling to promote blood pressure reduction is underscored by the observation that 80.3% of the Canadian population reports personal access to the internet, which includes 70%-76% of Canadians in the 2 lowest income quartiles, and 71% of older Canadians (aged 55-64 years).</s><s xml:id="_PVa3SUg"><ref type="bibr" target="#b33">34</ref> A more serious limitation of this trial concerns the inability to appropriately evaluate outcomes with the intention to treat analysis, due to contamination of the randomized treatment groups associated with an unforeseen e-programming problem.</s><s xml:id="_BpqnEEz">As noted above, the present trial served as a beta test to formally evaluate the BPAP, which was an initial version of the Heart and Stroke Foundation e-platform to promote blood pressure control.</s><s xml:id="_rvDuKMW">Arguably, the lack of appropriate evidence for a difference between the original randomized groups is not the same as appropriate evidence of a lack of difference.</s><s xml:id="_TdM4ar5"><ref type="bibr" target="#b34">35</ref> Therefore, we suggest that it is reasonable to consider the per protocol analysis in I-START as a credible evaluation of the primary outcomes.</s><s xml:id="_BYWJR7M">Future trials of e-counselling can prevent a similar problem of treatment contamination by restricting public access to the experimental e-counselling intervention, and by regularly monitoring (1) web site utilization and (2) the schedule of e-mails that are sent proactively to the e-counselling group vs controls.</s></p><p xml:id="_jEfYHh4"><s xml:id="_4sU64nM">In summary, the current findings suggest that there is merit in conducting additional trials of preventive e-counselling to determine long-term benefit (of at least 12 months) for the reduction of blood pressure and other cardiovascular risk factors.</s><s xml:id="_J5JFmvE">In addition, a follow-up trial of e-counselling is needed to establish whether this approach increases adherence to selfmanagement behaviours as measured by objective physiologic measures and validated assessments such as accelerometers and 24-hour urinary sodium analysis.</s><s xml:id="_2hNn2qD">The findings from the current study suggest that it may be feasible to use an e-counselling program to achieve (1) a reduction in blood pressure that is independent of the therapeutic benefit of medications, and (2) increased adherence to self-management behaviour for diet and exercise, independent of baseline levels of psychological distress.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_fb7ucgq">Erratum</head><p xml:id="_Vwa7jWd"><s xml:id="_FBAqNhG">In March/April 2012 issue, there was an error in the article "Focused 2012 Update of the Canadian Cardiovascular Society Atrial Fibrillation Guidelines: Recommendations for Stroke Prevention and Rate/Rhythm Control" by Skanes et al. (Can J Cardiol 2012;28:125-36).</s><s xml:id="_YFytkJ4">On page 129, in the second and fourth paragraphs, information provided about AVERROES trial was incorrect.</s><s xml:id="_mgtSfwz">The AVERROES trial included 5599 patients and compared apixaban to ASA only, not apixaban to ASA plus clopidogrel.</s><s xml:id="_HhE29pW">The corrected paragraphs appear below with changes in bold.</s></p><p xml:id="_qz6JuJj"><s xml:id="_92FuWCS">In the Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Strokes in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment (AVERROES) trial, 21 5599 AF patients (mean CHADS 2 ϭ 2.0) unsuitable for warfarin therapy were randomized double-blind to apixaban 5 mg twice daily (2.5 mg twice daily in selected patients) or to ASA (81-324 mg per day), and followed for a median of 1.1 years.</s><s xml:id="_b9CWhmK">The trial was stopped early because of marked outcome differences.</s><s xml:id="_6c6xGuv">Principal outcome rates (stroke or STE) were 3.7% per year with ASA vs 1.6% per year with apixaban (RR vs ASA 0.45; 0.32-0.62;</s><s xml:id="_MePb4ug">P Ͻ 0.001).</s><s xml:id="_Sf2TzmH">The rates of major bleeding were 1.2% per year with ASA vs 1.4% with apixaban (RR vs ASA 1.13; P Ͻ 0.57), with no significant differences in intracranial or GI bleeding.</s></p><p xml:id="_XB4atKx"><s xml:id="_9vHDpD7">In summary, compared with warfarin, both dabigatran and apixaban are more efficacious than warfarin for the prevention of stroke and STE, while rivaroxaban is noninferior to warfarin.</s><s xml:id="_dNtAtr7">Apixaban and dabigatran 110 mg causes less major bleeding than warfarin, while in comparison with warfarin there is no more major bleeding with either dabigatran 150 mg or rivaroxaban.</s><s xml:id="_YgZyD4R">There is significantly less intracranial bleeding with each of the new agents than with warfarin.</s></p><p xml:id="_kV9Zpjd"><s xml:id="_tVYhFZx">The recommendations made by previous national guidelines exercises were based upon a total of 2900 patients in the randomized trials of warfarin vs control, 3990 patients in the trials of ASA vs control and 3647 patients in the trials of warfarin vs ASA.</s><s xml:id="_yaMvcMX">The 3 recent trials randomized over 50,000 subjects to 1 of the new agents vs warfarin, and 5599 to apixaban vs ASA.</s><s xml:id="_ZY7v7c9">The 5 major primary prevention trials of warfarin compared with control showed an absolute risk reduction (ARR) for stroke of 2.7% per year, and a number-needed-to-treat (NNT) of 37 to avoid 1 stroke during 1 year of treatment.22</s><s xml:id="_CW5jNDB">In RE-LY, the ARR for dabigatran vs warfarin was 0.58% per year (NNT ϭ 172) and in ARISTOTLE the ARR for apixaban vs warfarin was 0.33% per year (NNT ϭ 303).</s><s xml:id="_KmTx92J">For intracranial hemorrhage, the ARRs are small (dabigatran ARR 0.44% per year, NNTϭ227; rivaroxaban ARR 0.2% per year, NNT ϭ 500; and apixaban ARR 0.47% per year, NNT ϭ 213).</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 .</head><label>1</label><figDesc><div><p xml:id="_f7naK25"><s xml:id="_ZShQys7">Figure 1.</s><s xml:id="_bQKtgHq">Patient flow diagram.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 .</head><label>1</label><figDesc><div><p xml:id="_W6QJnDZ"><s xml:id="_8h6Q2Ue">Baseline patient characteristics</s></p></div></figDesc><table><row><cell></cell><cell>0 e-mails (n ϭ 227)</cell><cell>1-7 e-mails (n ϭ 63)</cell><cell>Ն 8 e-mails (n ϭ 97)</cell><cell>P value</cell></row><row><cell>Age (y)</cell><cell>56.7 (55.7-57.7)</cell><cell>57.0 (55.2-58.8)</cell><cell>55.7 (54.3-57.0)</cell><cell>0.40</cell></row><row><cell>Sex: female (%)</cell><cell>120 (52.9)</cell><cell>39 (61.9)</cell><cell>70 (72.2)</cell><cell>0.005</cell></row><row><cell>Systolic BP, mm Hg</cell><cell>139.6 (137.3-141.9)</cell><cell>134.6 (129.9-139.3)*</cell><cell>143.3 (139.9-146.8)*</cell><cell>0.01</cell></row><row><cell>Diastolic BP, mm Hg</cell><cell>80.1 (78.8-81.5)</cell><cell>77.1 (74.6-79.5)</cell><cell>80.9 (78.9-82.8)</cell><cell>0.05</cell></row><row><cell>Pulse pressure, mm Hg</cell><cell>59.5 (57.6-61.4)</cell><cell>57.5 (53.7-61.4)</cell><cell>62.5 (59.5-65.4)</cell><cell>0.11</cell></row><row><cell>Household income, $CAD</cell><cell></cell><cell></cell><cell></cell><cell>0.63</cell></row><row><cell>Ͻ $60k</cell><cell>80 (35.2)</cell><cell>16 (25.4)</cell><cell>32 (33.0)</cell><cell></cell></row><row><cell>$60k-$99,999k</cell><cell>81 (35.7)</cell><cell>24 (38.1)</cell><cell>37 (38.1)</cell><cell></cell></row><row><cell>Ն $100k</cell><cell>66 (29.1)</cell><cell>23 (36.5)</cell><cell>28 (28.9)</cell><cell></cell></row><row><cell>BMI</cell><cell></cell><cell></cell><cell></cell><cell>0.85</cell></row><row><cell>Ͻ25</cell><cell>41 (18.1)</cell><cell>11 (17.5)</cell><cell>18 (18.6)</cell><cell></cell></row><row><cell>25-29.9</cell><cell>88 (38.8)</cell><cell>29 (46.0)</cell><cell>41 (42.3)</cell><cell></cell></row><row><cell>Ն30</cell><cell>98 (43.2)</cell><cell>23 (36.5)</cell><cell>38 (39.2)</cell><cell></cell></row><row><cell>Waist circumference</cell><cell></cell><cell></cell><cell></cell><cell>0.70</cell></row><row><cell>F Ͼ 88 cm, M Ͼ 102 cm</cell><cell>143 (63.0)</cell><cell>36 (57.1)</cell><cell>60 (61.9)</cell><cell></cell></row><row><cell>Cardiovascular risk factors</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Total cholesterol, mmol/L</cell><cell>5.3 (5.2-5.4)</cell><cell>5.1 (4.8-5.3)</cell><cell>5.4 (5.1-5.6)</cell><cell>0.23</cell></row><row><cell>Diabetes</cell><cell>16 (7.0)</cell><cell>5 (7.9)</cell><cell>2 (2.1)</cell><cell>0.17</cell></row><row><cell>Smoking</cell><cell>8 (3.5)</cell><cell>3 (4.8)</cell><cell>6 (6.3)</cell><cell>0.55</cell></row><row><cell>Framingham 10-y index of absolute risk</cell><cell>9.5 (8.7-10.2)</cell><cell>8.8 (7.5-10.1)</cell><cell>9.1 (8.1-10.0)</cell><cell>0.65</cell></row><row><cell cols="2">Data are shown as mean (95% confidence interval) or n (%).</cell><cell></cell><cell></cell><cell></cell></row></table><note xml:id="_gfMtc3e"><p><s xml:id="_g9qDn4v">BMI, body mass index calculated as weight (kg)/height (m 2 ); BP, blood pressure; F, female; k, thousand; M, male.</s><s xml:id="_YXvAB2E">* Bonferroni-corrected post hoc comparison: P Ͻ 0.05.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2 .</head><label>2</label><figDesc><div><p xml:id="_gXsPnux"><s xml:id="_dBUCzYK">Baseline medication</s></p></div></figDesc><table><row><cell></cell><cell>0</cell><cell>1-7</cell><cell>Ն 8</cell><cell></cell></row><row><cell></cell><cell>e-mails</cell><cell>e-mails</cell><cell>e-mails</cell><cell>P</cell></row><row><cell>Medications</cell><cell>(n ϭ 227)</cell><cell>(n ϭ 63)</cell><cell>(n ϭ 97)</cell><cell>value</cell></row><row><cell>␤-Blocker</cell><cell>18 (7.9)</cell><cell>10 (15.9)</cell><cell>6 (6.2)</cell><cell>0.08</cell></row><row><cell>Calcium channel blocker</cell><cell cols="3">39 (17.2) 17 (27.0) 15 (15.5)</cell><cell>0.14</cell></row><row><cell>ACE inhibitor</cell><cell cols="3">67 (29.5) 20 (31.7) 33 (34.0)</cell><cell>0.72</cell></row><row><cell>Diuretic</cell><cell cols="3">70 (30.8) 22 (34.9) 32 (33.0)</cell><cell>0.81</cell></row><row><cell>ARB</cell><cell>45 (19.8)</cell><cell cols="2">9 (14.3) 13 (13.4)</cell><cell>0.30</cell></row><row><cell>Ն 1 Antihypertensive drug</cell><cell cols="3">160 (70.5) 49 (77.8) 69 (71.1)</cell><cell>0.52</cell></row><row><cell>Ն 1 Lipid lowering drug</cell><cell cols="3">42 (18.5) 19 (30.2) 21 (21.6)</cell><cell>0.13</cell></row></table><note xml:id="_CfhykbH"><p><s xml:id="_V6UV9TH">Data are shown as n (%).</s><s xml:id="_M3rnKMh">ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blocker.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 3 .</head><label>3</label><figDesc><div><p xml:id="_ZBxhHr2"><s xml:id="_cutMRns">Change in clinical outcomes after 4-month intervention according to dosage of e-counselling: per protocol analysis</s></p></div></figDesc><table><row><cell>E-counselling groups</cell></row></table></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div><head xml:id="_zcZ7qpP">Acknowledgements</head><p xml:id="_erudt3a"><s xml:id="_VHb64YQ">The thank the participants, collaborating organizations, and family physicians that made this trial possible.</s><s xml:id="_dHPvV9w">The <rs type="projectName">Blood Pressure Action Plan</rs> has been rebranded as <rs type="funder">Heart and Stroke Foundation Health</rs> <rs type="programName">e-Support program</rs>.</s></p><p xml:id="_waznb34"><s xml:id="_p3wysx5">Trial Registration at <ref type="url" target="http://www.clinicaltrials.gov">www.clinicaltrials.gov</ref>:</s><s xml:id="_ZnJwhwB"><rs type="grantNumber">NCT00815477</rs>.</s></p></div>
<div><head xml:id="_KvAxMVf">Funding Sources</head><p xml:id="_bT5SHGn"><s xml:id="_XgWMHsy">Peer-reviewed grant from <rs type="funder">Canadian Stroke Network</rs>.</s></p></div>
<div><head xml:id="_RZmhDnK">Disclosures</head><p xml:id="_u2nZFD2"><s xml:id="_XuxyhtM"><rs type="person">Dr Nolan</rs> has provided limited consultation on telehealth and e-health to the <rs type="institution">Unilever Corporation</rs> and <rs type="institution">Abbott Laboratories</rs>, however, this activity has no financial or research association with this clinical trial.</s><s xml:id="_huM77gv">The other authors have no conflicts of interest to disclose.</s></p></div>
			</div>
			<listOrg type="funding">
				<org type="funded-project" xml:id="_rVUjyNn">
					<orgName type="project" subtype="full">Blood Pressure Action Plan</orgName>
					<orgName type="program" subtype="full">e-Support program</orgName>
				</org>
				<org type="funding" xml:id="_a9YHxZa">
					<idno type="grant-number">NCT00815477</idno>
				</org>
			</listOrg>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main" xml:id="_uYZnTtu">The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 -therapy</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Hackam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">A</forename><surname>Khan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">R</forename><surname>Hemmelgarn</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_6ttjGky">Can J Cardiol</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="249" to="258" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hackam DG, Khan NA, Hemmelgarn BR, et al. The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 -therapy. Can J Cardiol 2010;26:249-58.</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main" xml:id="_tk2zHGV">Home-based telehealth: a review and metaanalysis</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Dellifraine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Dansky</surname></persName>
		</author>
		<idno type="DOI">10.1258/jtt.2007.070709</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Q2me5hB">J Telemed Telecare</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="62" to="66" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Dellifraine JL, Dansky KH. Home-based telehealth: a review and meta- analysis. J Telemed Telecare 2008;14:62-6.</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main" xml:id="_AmBbY6Z">Home telemonitoring for congestive heart failure: a systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">J</forename><surname>Polisena</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Tran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Cimon</surname></persName>
		</author>
		<idno type="DOI">10.1258/jtt.2009.090406</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_9UmY7TE">J Telemed Telecare</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="68" to="76" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Polisena J, Tran K, Cimon K, et al. Home telemonitoring for congestive heart failure: a systematic review and meta-analysis. J Telemed Telecare 2010;16:68-76.</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main" xml:id="_tjqvG6Q">Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">O</forename><surname>Dickinson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Mason</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Nicolson</surname></persName>
		</author>
		<idno type="DOI">10.1097/01.hjh.0000199800.72563.26</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_WZ5j5SG">J Hypertens</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="215" to="233" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Dickinson HO, Mason JM, Nicolson DJ, et al. Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials. J Hypertens 2006;24:215-33.</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main" xml:id="_MtFmgT8">Telehealth interventions for the secondary prevention of coronary heart disease: a systematic review</title>
		<author>
			<persName><forename type="first">L</forename><surname>Neubeck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Redfern</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Fernandez</surname></persName>
		</author>
		<idno type="DOI">10.1097/hjr.0b013e32832a4e7a</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_SdbzDqm">Eur J Cardiovasc Prev Rehabil</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="281" to="289" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Neubeck L, Redfern J, Fernandez R, et al. Telehealth interventions for the secondary prevention of coronary heart disease: a systematic review. Eur J Cardiovasc Prev Rehabil 2009;16:281-9.</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main" xml:id="_ca87RcW">Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Whelton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Chin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Xin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>He</surname></persName>
		</author>
		<idno type="DOI">10.7326/0003-4819-136-7-200204020-00006</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_yGNQRyn">Ann Intern Med</title>
		<imprint>
			<biblScope unit="volume">136</biblScope>
			<biblScope unit="page" from="493" to="503" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Whelton SP, Chin A, Xin X, He J. Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials. Ann Intern Med 2002;136:493-503.</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main" xml:id="_Wxxm8f8">Psychosocial determinants of health behaviour change in an e-counseling intervention for hypertension</title>
		<author>
			<persName><forename type="first">S</forename><surname>Durrani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Irvine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Nolan</surname></persName>
		</author>
		<idno type="DOI">10.1155/2012/191789</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_QUKKeH4">Int J Hypertens</title>
		<imprint>
			<biblScope unit="page">191789</biblScope>
			<date type="published" when="2012">2012. 2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Durrani S, Irvine J, Nolan RP. Psychosocial determinants of health be- haviour change in an e-counseling intervention for hypertension. Int J Hy- pertens 2012;2012:191789.</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main" xml:id="_eC6Tfh8">Stages of change and decisional balance for 12 problem behaviors</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">O</forename><surname>Prochaska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">F</forename><surname>Velicer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Rossi</surname></persName>
		</author>
		<idno type="DOI">10.1037//0278-6133.13.1.39</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ms7hjwp">Health Psychol</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="39" to="46" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Prochaska JO, Velicer WF, Rossi JS, et al. Stages of change and decisional balance for 12 problem behaviors. Health Psychol 1994;13:39-46.</note>
</biblStruct>

<biblStruct xml:id="b8">
	<monogr>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">R</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Rollnick</surname></persName>
		</author>
		<title level="m" xml:id="_jR6VVVM">Motivational interviewing: preparing people for change</title>
		<meeting><address><addrLine>New York</addrLine></address></meeting>
		<imprint>
			<publisher>Guilford Press</publisher>
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Miller WR, Rollnick S. Motivational interviewing: preparing people for change. New York: Guilford Press, 2002.</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main" xml:id="_AjRv28d">Internet-administered cognitive behavior therapy for health problems: a systematic review</title>
		<author>
			<persName><forename type="first">P</forename><surname>Cuijpers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Van Straten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Andersson</surname></persName>
		</author>
		<idno type="DOI">10.1007/s10865-007-9144-1</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Tts6ybg">J Behav Med</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="169" to="177" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Cuijpers P, van Straten A, Andersson G. Internet-administered cognitive behavior therapy for health problems: a systematic review. J Behav Med 2008;31:169-77.</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main" xml:id="_bv246SA">Psychometric properties of the beck depression inventory: twenty-five years of evaluation</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">T</forename><surname>Beck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Steer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Carbin</surname></persName>
		</author>
		<idno type="DOI">10.1016/0272-7358(88)90050-5</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_m8cST6J">Clinical Psychology Review</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="77" to="100" />
			<date type="published" when="1987">1987</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Beck AT, Steer RA, Carbin MG. Psychometric properties of the beck depression inventory: twenty-five years of evaluation. Clinical Psychology Review 1987;8:77-100.</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main" xml:id="_SfYUDrZ">A global measure of perceived stress</title>
		<author>
			<persName><forename type="first">S</forename><surname>Cohen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kamarck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Mermelstein</surname></persName>
		</author>
		<idno type="DOI">10.2307/2136404</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_UcpdHJN">J Health Soc Behav</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="385" to="396" />
			<date type="published" when="1983">1983</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav 1983;24:385-96.</note>
</biblStruct>

<biblStruct xml:id="b12">
	<monogr>
		<idno type="DOI">10.1016/s1362-3265(97)80724-9</idno>
		<title level="m" xml:id="_KjjVfQk">Canada food guide to healthy eating</title>
		<imprint>
			<publisher>Health Canada</publisher>
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Health Canada. Canada food guide to healthy eating-e/f. 1997.</note>
</biblStruct>

<biblStruct xml:id="b13">
	<monogr>
		<title level="m" type="main" xml:id="_wCjuDnj">Canada&apos;s physical activity guide to healthy active living</title>
		<idno type="DOI">10.1093/pch/18.6.301</idno>
		<imprint>
			<date type="published" when="1998">1998</date>
			<publisher>Health Canada</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Health Canada. Canada&apos;s physical activity guide to healthy active living. 1998.</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main" xml:id="_sxvfpxJ">Comparative effectiveness of lifestyle interventions on cardiovascular risk factors among a dutch overweight working population: a randomized controlled trial</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Dekkers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Van Wier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Ariens</surname></persName>
		</author>
		<idno type="DOI">10.1186/1471-2458-11-49</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_x6RmK8V">BMC Public Health</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page">49</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Dekkers JC, van Wier MF, Ariens GA, et al. Comparative effectiveness of lifestyle interventions on cardiovascular risk factors among a dutch over- weight working population: a randomized controlled trial. BMC Public Health 2011;11:49.</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main" xml:id="_HpYmQFy">Alifework: a randomised controlled trial of a distance counselling lifestyle programme for weight control among an overweight working population [isrctn04265725]</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Van Wier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Ariens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Dekkers</surname></persName>
		</author>
		<idno type="DOI">10.1186/1471-2458-6-140</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_8BAzntb">BMC Public Health</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">140</biblScope>
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note type="raw_reference">van Wier MF, Ariens GA, Dekkers JC, et al. Alifework: a randomised controlled trial of a distance counselling lifestyle programme for weight control among an overweight working population [isrctn04265725]. BMC Public Health 2006;6:140.</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main" xml:id="_eJ5UCUG">The extensive lifestyle management intervention (ELMI) after cardiac rehabilitation: a 4-year randomized controlled trial</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Lear</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Spinelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Linden</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Warauhv">Am Heart J</title>
		<imprint>
			<biblScope unit="volume">152</biblScope>
			<biblScope unit="page" from="333" to="339" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lear SA, Spinelli JJ, Linden W, et al. The extensive lifestyle management intervention (ELMI) after cardiac rehabilitation: a 4-year randomized controlled trial. Am Heart J 2006;152:333-9.</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main" xml:id="_9YJqRNC">One-year follow-up of a therapeutic lifestyle intervention targeting cardiovascular disease risk</title>
		<author>
			<persName><forename type="first">A</forename><surname>Wister</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Loewen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kennedy-Symonds</surname></persName>
		</author>
		<idno type="DOI">10.1503/cmaj.061059</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_x2ztAQ9">CMAJ</title>
		<imprint>
			<biblScope unit="volume">177</biblScope>
			<biblScope unit="page" from="859" to="865" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Wister A, Loewen N, Kennedy-Symonds H, et al. One-year follow-up of a therapeutic lifestyle intervention targeting cardiovascular disease risk. CMAJ 2007;177:859-65.</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main" xml:id="_nbz75kS">Utilization of the internet to deliver cardiac rehabilitation at a distance: a pilot study</title>
		<author>
			<persName><forename type="first">A</forename><surname>Zutz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ignaszewski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bates</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Lear</surname></persName>
		</author>
		<idno type="DOI">10.1089/tmj.2006.0051</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_KErCy3R">Telemed J E Health</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="323" to="330" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Zutz A, Ignaszewski A, Bates J, Lear SA. Utilization of the internet to deliver cardiac rehabilitation at a distance: a pilot study. Telemed J E Health 2007;13:323-30.</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main" xml:id="_Z4McFCu">Therapeutic benefit of a preventive telehealth strategy in the community outreach heart health and risk reduction trial: a randomized controlled trial</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Nolan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Reg</forename><surname>Upshur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Lynn</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.amjcard.2010.10.050</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_TtbS7Rm">Am J Cardiol</title>
		<imprint>
			<biblScope unit="volume">107</biblScope>
			<biblScope unit="page" from="690" to="696" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Nolan RP, Upshur REG, Lynn H, et al. Therapeutic benefit of a preventive telehealth strategy in the community outreach heart health and risk reduction trial: a randomized controlled trial. Am J Cardiol 2011;107:690-6.</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main" xml:id="_nZWQ7nJ">A case-management system for coronary risk factor modification after acute myocardial infarction</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">F</forename><surname>Debusk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">H</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">R</forename><surname>Superko</surname></persName>
		</author>
		<idno type="DOI">10.7326/0003-4819-120-9-199405010-00001</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_YFs6s2t">Ann Intern Med</title>
		<imprint>
			<biblScope unit="volume">120</biblScope>
			<biblScope unit="page" from="721" to="729" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
	<note type="raw_reference">DeBusk RF, Miller NH, Superko HR, et al. A case-management system for coronary risk factor modification after acute myocardial infarction. Ann Intern Med 1994;120:721-9.</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main" xml:id="_ZwvDgGV">Choice of secondary prevention improves risk factors after acute coronary syndrome: 1-year follow-up of the choice (choice of health options in prevention of cardiovascular events) randomised controlled trial</title>
		<author>
			<persName><forename type="first">J</forename><surname>Redfern</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Briffa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Ellis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">B</forename><surname>Freedman</surname></persName>
		</author>
		<idno type="DOI">10.1136/hrt.2008.150870</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_SPY7DB7">Heart</title>
		<imprint>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="page" from="468" to="475" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Redfern J, Briffa T, Ellis E, Freedman SB. Choice of secondary prevention improves risk factors after acute coronary syndrome: 1-year follow-up of the choice (choice of health options in prevention of cardiovascular events) randomised controlled trial. Heart 2009;95:468-75.</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main" xml:id="_hQNdjqg">Clinical trial of an internet-based case management system for secondary prevention of heart disease</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">H</forename><surname>Southard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Southard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Nuckolls</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_KXCUt6Q">J Cardiopulm Rehabil</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="341" to="348" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Southard BH, Southard DR, Nuckolls J. Clinical trial of an internet-based case management system for secondary prevention of heart disease. J Car- diopulm Rehabil 2003;23:341-8.</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main" xml:id="_rwDfyp4">Coaching patients on achieving cardiovascular health (COACH): a multicenter randomized trial in patients with coronary heart disease</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Vale</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">V</forename><surname>Jelinek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Best</surname></persName>
		</author>
		<idno type="DOI">10.1001/archinte.163.22.2775</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_DpPnYNE">Arch Intern Med</title>
		<imprint>
			<biblScope unit="volume">163</biblScope>
			<biblScope unit="page" from="2775" to="2783" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Vale MJ, Jelinek MV, Best JD, et al. Coaching patients on achieving cardiovascular health (COACH): a multicenter randomized trial in pa- tients with coronary heart disease. Arch Intern Med 2003;163:2775-83.</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main" xml:id="_86s6weX">Health behaviour advice from health professionals to canadian adults with hypertension: results from a national survey</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Walker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Gee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bancej</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_5tqgEZn">Can J Cardiol</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="446" to="454" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Walker RL, Gee ME, Bancej C, et al. Health behaviour advice from health professionals to canadian adults with hypertension: results from a national survey. Can J Cardiol 2011;27:446-54.</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main" xml:id="_4AyVbpA">Psychosocial interventions for smoking cessation in patients with coronary heart disease</title>
		<author>
			<persName><forename type="first">J</forename><surname>Barth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Critchley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bengel</surname></persName>
		</author>
		<idno type="DOI">10.1002/14651858.cd006886</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_4GuqysF">Cochrane Database Syst Rev</title>
		<imprint>
			<biblScope unit="page">6886</biblScope>
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Barth J, Critchley J, Bengel J. Psychosocial interventions for smoking cessation in patients with coronary heart disease. Cochrane Database Syst Rev 2008:CD006886.</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main" xml:id="_3w5G6bk">Effects of web-and computer-based smoking cessation programs: meta-analysis of randomized controlled trials</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Myung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">D</forename><surname>Mcdonnell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Kazinets</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">G</forename><surname>Seo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Moskowitz</surname></persName>
		</author>
		<idno type="DOI">10.1001/archinternmed.2009.109</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_SzNJUuC">Arch Intern Med</title>
		<imprint>
			<biblScope unit="volume">169</biblScope>
			<biblScope unit="page" from="929" to="937" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Myung SK, McDonnell DD, Kazinets G, Seo HG, Moskowitz JM. Effects of web-and computer-based smoking cessation programs: meta-analysis of randomized controlled trials. Arch Intern Med 2009; 169:929-37.</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main" xml:id="_VZtWK2B">Can individuals meet multiple physical activity and dietary behavior goals?</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Young</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">M</forename><surname>Vollmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>King</surname></persName>
		</author>
		<idno type="DOI">10.5993/ajhb.33.3.6</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_dAhGKjH">Am J Health Behav</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="277" to="286" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Young DR, Vollmer WM, King AC, et al. Can individuals meet multiple physical activity and dietary behavior goals? Am J Health Behav 2009;33: 277-86.</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main" xml:id="_RcknS3f">Medication adherence and persistence as the cornerstone of effective antihypertensive therapy</title>
		<author>
			<persName><forename type="first">M</forename><surname>Burnier</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.amjhyper.2006.04.006</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_rCqRtTd">Am J Hypertens</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="1190" to="1196" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Burnier M. Medication adherence and persistence as the cornerstone of effective antihypertensive therapy. Am J Hypertens 2006;19:1190-6.</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main" xml:id="_CGxkBFd">TEACH: trial of education and compliance in heart dysfunction chronic disease and heart failure (HF) as an increasing problem</title>
		<author>
			<persName><forename type="first">F</forename><surname>Gwadry-Sridhar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Guyatt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O'</forename><surname>Brien</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_hv8fW52">Contemp Clin Trials</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="905" to="918" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Gwadry-Sridhar F, Guyatt G, O&apos;Brien B, et al. TEACH: trial of education and compliance in heart dysfunction chronic disease and heart failure (HF) as an increasing problem. Contemp Clin Trials 2008;29:905-18.</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main" xml:id="_8JybNZV">Persistence with hypertension treatment among community-dwelling BC seniors</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Morgan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Yan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_jkj32gc">Can J Clin Pharmacol</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="267" to="273" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Morgan SG, Yan L. Persistence with hypertension treatment among com- munity-dwelling BC seniors. Can J Clin Pharmacol 2004;11:e267-73.</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main" xml:id="_9NHmYGU">Estimating the benefits of patient and physician adherence to cardiovascular prevention guidelines: the myhealthcheckup survey</title>
		<author>
			<persName><forename type="first">S</forename><surname>Grover</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Coupal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kouache</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.cjca.2011.01.007</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_JC67kvU">Can J Cardiol</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="159" to="166" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Grover S, Coupal L, Kouache M, et al. Estimating the benefits of patient and physician adherence to cardiovascular prevention guidelines: the my- healthcheckup survey. Can J Cardiol 2011;27:159-66.</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main" xml:id="_2kdbYkq">Getting a second opinion: health information and the internet</title>
		<author>
			<persName><forename type="first">C</forename><surname>Underhill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Mckeown</surname></persName>
		</author>
		<idno type="DOI">10.1080/15398280802121646</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_NzkBBsF">Health Rep</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="65" to="69" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Underhill C, McKeown L. Getting a second opinion: health information and the internet. Health Rep 2008;19:65-9.</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title/>
		<idno type="DOI">10.24095/hpcdp.30.4.02</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_pkDdQka">Canadian internet use survey</title>
		<imprint>
			<date type="published" when="2010">2010. 2011</date>
			<publisher>Statistics Canada</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Statistics Canada. Canadian internet use survey: 2010. 2011.</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main" xml:id="_VBzqXfb">Active-control clinical trials to establish equivalence or noninferiority: methodological and statistical concepts linked to quality</title>
		<author>
			<persName><forename type="first">M</forename><surname>Gomberg-Maitland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Frison</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Halperin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_73cJfuR">Am Heart J</title>
		<imprint>
			<biblScope unit="volume">146</biblScope>
			<biblScope unit="page" from="398" to="403" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Gomberg-Maitland M, Frison L, Halperin JL. Active-control clinical tri- als to establish equivalence or noninferiority: methodological and statisti- cal concepts linked to quality. Am Heart J 2003;146:398-403.</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
